Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty

Journal of Infection

Volumn 61, Issue 2, 2010, Pages 125-132

  Bernard, Louis ^a,b   Legout, Laurence ^a   Zürcher Pfund, Line ^a   Stern, Richard ^a   Rohner, Peter ^a   Peter, Robin ^a   Assal, Mathieu ^a   Lew, Daniel ^a   Hoffmeyer, Pierre ^a   Uçkay, Ilker ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b University Hospitals of Tours   (France)

Author keywords

Duration; Infection; Oral antibiotic; Prosthetic joint; Surgery

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGED; ARTHRODESIS; ARTHROPLASTY; ARTICLE; BONE AND JOINT INFECTIONS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFECTION; JOINT PROSTHESIS; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROSTHETIC JOINT INFECTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; ARTHRITIS, INFECTIOUS; BACTERIAL INFECTIONS; FOLLOW UP; PROSTHESIS-RELATED INFECTIONS; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; ARTHROPLASTY; BACTERIAL INFECTIONS; DEBRIDEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955057039     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.05.005     Document Type: Article

References (28)

1. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. N Eng J Med 2004, 351:1645-1654.
2. Zimmerli W., Widmer A.F., Blatter M., Frei R., Ochsner P.E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 1998, 279:1537-1541.
3. Bengtson S. Prosthetic osteomyelitis with special reference to the knee: risks, treatment and costs. Ann Med 1993, 25:523-529.
4. Uçkay I., Pittet D., Vaudaux P., Sax H., Lew D., Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Ann Med 2009, 41:109-119.
5. Bernard L., Hoffmeyer P., Assal M., Vaudaux P., Schrenzel J., Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 2004, 53:127-129.
6. Trampuz A., Zimmerli W. Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs 2006, 66:1089-1105.
7. Kösters K., van Crevel R., Sturm P.D., Willem Schreurs B., de Waal Malefijt M.C., van Kampen A., et al. Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period. Int Orthop 2008, 33:1249-1254.
8. Laffer R.R., Graber P., Ochsner P.E., Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006, 12:433-439.
9. Volin S.J., Hinrichs S.H., Garvin K.L. Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 2004, 427:94-100.
10. Mermel L.A., Farr B.M., Sherertz R.J., Raad I.I., O'Grady N., Harris J.S., et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2001, 22:222-242.
11. Pulcini C., Couadau T., Bernard E., Lorthat-Jacob A., Bauer T., Cua E., et al. Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis 2008, 27:1227-1232.
12. Uçkay I., Vernaz-Hegi N., Harbarth S., Stern R., Legout L., Vauthey L., et al. Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect 2009, 58:205-212.
13. Lübbeke A., Stern R., Garavaglia G., Zürcher L., Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum 2007, 57:327-334.
14. Wayne P. Performance standards for antimicrobial susceptibility testing 2007, Clinical and Laboratory Standards Institute, 17th informational supplement (Standard M100-S17).
15. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007, 165:710-718.
16. Kilgus D.J., Howe D.J., Strang A. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 2002, 404:116-124.
17. Byren I., Bejon P., Atkins B.L., Angus B., Masters S., McLardy-Smith P., et al. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009, 63:1264-1271.
18. Betsch B.Y., Eggli S., Siebenrock K.A., Täuber M.G., Mühlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008, 46:1221-1226.
19. Marculescu C.E., Berbari E.F., Hanssen A.D., Steckelberg J.M., Harmsen S.W., Mandrekar J.N., et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006, 42:471-478.
20. Brandt C.M., Sistrunk W.W., Duffy M.C., Hanssen A.D., Steckelberg J.M., Ilstrup D.M., et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997, 24:914-919.
21. Farhad R., Roger P.M., Albert C., Pélligri C., Touati C., Dellamonica P., et al. Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis 2009, 29:217-222.
22. Smilack J.D., Flittie W.H., Williams T.W. Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother 1976, 9:169-171.
23. Daver N.G., Shelburne S.A., Atmar R.L., Giordano T.P., Stager C.E., Reitman C.A., et al. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infect 2007, 54:539-544.
24. Darley E.S., MacGowan A.P. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother 2004, 53:928-935.
25. Toma M.B., Smith K.M., Martin C.A., Rapp R.P. Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Orthopedics 2006, 29:497-501.
26. Berendt A.R., Peters E.J., Bakker K., Embil J.M., Eneroth M., Hinchliffe R.J., et al. Specific guidelines for treatment of diabetic foot osteomyelitis. Diabetes Metab Res Rev 2008, 24:190-191.
27. Heldman A.W., Hartert T.V., Ray S.C., Daoud E.G., Kowalski T.E., Pompili V.J., et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996, 101:68-76.
28. Vaudaux P., Kelley W.L., Lew D.P. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis 2006, 43:968-970.